Clik here to view.
CDISC and HL7 Jointly Release Mapping Guide to Facilitate the Use of...
AUSTIN, Texas – 01 Sep 2021 – CDISC and HL7 announced the release of the FHIR to CDISC Joint Mapping Implementation Guide, freely available on the CDISC and HL7 websites, to facilitate the use of...
View ArticleClik here to view.
SCIEX Builds on Cadence of Innovation in Biopharma With Biologics Explorer
FRAMINGHAM, Mass. SCIEX, a global leader in life science analytical technologies and Danaher operating company, launches Biologics Explorer software, enabling customers to acquire insights from...
View ArticleClik here to view.
EdiGene Announces Clinical Sites Activation and First Patient Enrolled in...
BEIJING & CAMBRIDGE, Mass. EdiGene, Inc. (“Company”, or “EdiGene”), today announced the first patient enrolled in multicenter Phase I clinical study of its investigational gene-editing...
View ArticleClik here to view.
Bio-Thera Solutions Announces Commercialization and License Agreement for...
GUANGZHOU, China Bio-Thera Solutions, Ltd. (688177.SH) today announced that it has entered into a commercialization and license agreement with Sandoz to commercialize BAT1706, an anti- vascular...
View ArticleClik here to view.
Celltrion’s monoclonal antibody treatment for COVID-19, regdanvimab (CT-P59)...
INCHEON, South Korea Celltrion Group announced that the Korean Ministry of Food and Drug Safety (MFDS) approved regdanvimab (CT-P59), a monoclonal antibody treatment for COVID-19 for the extended...
View ArticleClik here to view.
City of Hope and Griffith University Researchers Use Novel Method to Block...
DUARTE, Calif. Researchers at City of Hope, a world-renowned research and treatment organization for cancer and diabetes, and Menzies Health Institute Queensland at Griffith University have...
View ArticleClik here to view.
Celltrionのモノクローナル抗体治療薬、Regdanvimab(CT-P59)は、韓国食品医薬品安全庁(MFDS)からCOVID-19感染症治療薬と...
INCHEON, South Korea （ビジネスワイヤ） — Celltrion...
View ArticleClik here to view.
Clik here to view.
Arcturus Therapeutics Announces Approval from Vietnam Ministry of Health to...
SAN DIEGO Arcturus Therapeutics Holdings Inc. (the “Company”, “Arcturus”, Nasdaq: ARCT), a leading clinical-stage messenger RNA medicines company focused on the development of infectious disease...
View ArticleClik here to view.
AnHeart Therapeutics Announces Formation of Scientific Advisory Board
NEW YORK & HANGZHOU, China AnHeart Therapeutics (“AnHeart”), a clinical-stage global biopharmaceutical company committed to developing novel cancer therapies, announced today the formation of...
View ArticleClik here to view.
Arcturus Therapeutics Announces Meeting with President of Vietnam and CEO of...
SAN DIEGO Arcturus Therapeutics Holdings Inc. (the “Company”, “Arcturus”, Nasdaq: ARCT), a leading clinical-stage messenger RNA medicines company focused on the development of infectious disease...
View ArticleClik here to view.
SpeeDx与SynGenis合作促进定制寡核苷酸合成
澳大利亚悉尼和本特利 (美国商业资讯)–创新型分子诊断解决方案开发商SpeeDx Pty, Ltd.宣布投资SynGenis Pty Ltd.，后者是西澳大利亚州的一家经验丰富的寡核苷酸生产商。此次合作将加强SpeeDx的内部能力，有助于扩大生产规模，同时还可促进和提升分子诊断所需重要原材料的自主供应能力。 本新闻稿包含多媒体。此处查看新闻稿全文：...
View ArticleClik here to view.
SpeeDxとSynGenisがカスタムオリゴヌクレオチド合成で提携
豪シドニー & ベントレー （ビジネスワイヤ） — 革新的な分子診断ソリューションの開発を手掛けるSpeeDx Pty, Ltd.は、西オーストラリアを拠点とする経験豊富なオリゴヌクレオチド製造企業SynGenis Pty...
View ArticleClik here to view.
マウィDNAテクノロジーズが富士フイルムとの提携を発表
米カリフォルニア州ヘイワード （ビジネスワイヤ） — マウィDNAテクノロジーズ（マウィ）は、当社のiSWAB生体試料採取技術を日本市場で提供すべく、生物医学業界大手の富士フイルム和光純薬株式会社と販売店契約を締結しました。 マウィでアジア太平洋地域の事業開発を担当するAtsushi...
View ArticleClik here to view.
Parse Biosciences Extends RNA-Seq Kit Reach to Australia and New Zealand...
SEATTLE Parse Biosciences today announced a partnership with Decode Science to provide Parse’s single-cell RNA-seq solution to the Australian and New Zealand markets. Under an agreement between the...
View ArticleClik here to view.
The Jackson Laboratory Announces Acquisition of Charles River Laboratories Japan
FARMINGTON, Conn. & YOKOHAMA, Japan The Jackson Laboratory (JAX), a U.S.-based nonprofit biomedical research institution, announced today that it has acquired Charles River Laboratories Japan’s...
View ArticleClik here to view.
米国ジャクソン研究所がチャールス・リバー日本法人の買収を発表
YOKOHAMA, Japan & FARMINGTON, Conn. 米国コネチカット州ファーミントンに本拠を置く、非営利の生物医学研究機関であるジャクソン研究所(JAX)は本日、日本チャールス・リバー株式会社のRMS（リサーチモデルサービス/Research Models and...
View ArticleClik here to view.
Cyclo Therapeutics Announces Abstract Accepted for Poster Presentation at the...
GAINESVILLE, Fla. Cyclo Therapeutics, Inc. (Nasdaq: CYTH) (“Cyclo Therapeutics” or the “Company”), a clinical stage biotechnology company dedicated to developing life-changing medicines through...
View ArticleClik here to view.
FitPet Plans to Establish ‘Global Integrated Pet Lifestyle Platform’ Based on...
SEOUL, South Korea “We are creating a one-stop ecosystem for effective healthcare for pets.” The age has come when pets can be checked and managed with a simple diagnostic kit without having to go...
View ArticleClik here to view.
BeiGene and Nanolek Announce Approval in Russia for BRUKINSA® (Zanubrutinib)...
CAMBRIDGE, Mass. & BEIJING & MOSCOW BeiGene (NASDAQ: BGNE; HKEX: 06160), a global, science-driven biotechnology company focused on developing innovative and affordable medicines to improve...
View Article